Back
Rocket Pharmaceuticals, Inc. Vs. NovaBay Pharmaceuticals, Inc. Industry Stock Comparison
Sell
28
RCKT
Rocket Pharmaceuticals, Inc.
Last Price:
$3.48
Seasonality Move:
4.26%
Buy
71
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$4.81
Seasonality Move:
10.47%
Sell
28
Rocket Pharmaceuticals, Inc. (RCKT)
is a Sell
Is Rocket Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rocket Pharmaceuticals, Inc. [RCKT] share price is $3.48. The Score for RCKT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
RCKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
NovaBay Pharmaceuticals, Inc. (NBY)
is a Buy
Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $4.85. The Score for NBY is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals, Inc.'s stock price today?
-
The Rocket Pharmaceuticals, Inc. share price today is $3.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCKT is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals, Inc.'s stock price today?
-
The NovaBay Pharmaceuticals, Inc. share price today is $4.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RCKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.94 | Buy |
| Relative Strength Index (14 RSI): | 54.12 | Buy |
| Chaikin Money Flow: | -35578 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.12 - 3.5) | Buy |
| Bollinger Bands (100): | (3.04 - 3.64) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.98 | Buy |
| Relative Strength Index (14 RSI): | 72.65 | Buy |
| Chaikin Money Flow: | 213630 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.87 - 3.93) | Buy |
| Bollinger Bands (100): | (0.61 - 2.75) | Buy |
RCKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.39 | Buy |
| 20-day SMA: | 3.38 | Buy |
| 50-day SMA: | 3.41 | Buy |
| 200-day SMA: | 4.15 | Sell |
| 8-day EMA: | 2.84 | Buy |
| 20-day EMA: | 1.72 | Buy |
| 50-day EMA: | 0.83 | Buy |
| 200-day EMA: | 0.23 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.31 | Buy |
| 20-day SMA: | 2.76 | Buy |
| 50-day SMA: | 1.76 | Buy |
| 200-day SMA: | 1.14 | Buy |
| 8-day EMA: | 4.29 | Buy |
| 20-day EMA: | 3.2 | Buy |
| 50-day EMA: | 2.09 | Buy |
| 200-day EMA: | 0.82 | Buy |
Rocket Pharmaceuticals, Inc. Earnings Growth & RCKT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and an increase next year of $0.73 per share.
NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Rocket Pharmaceuticals, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||